5-Azacitidine has limited therapeutic activity in myelofibrosis

Leukemia. 2009 Jan;23(1):180-2. doi: 10.1038/leu.2008.136. Epub 2008 May 29.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Aged
  • Azacitidine / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Primary Myelofibrosis / drug therapy*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Azacitidine